To determine the pathological significance of SARM1 phosphorylation at Ser-548 in vivo, we used a rotenone-treated PD mouse model in which rotenone was manipulated to be gradually released with diffusion in the subcutaneous area over a period of 28 days. Here, SARM1 is linked to Parkinson disease.